Washington Trust Advisors, Inc. Moderna, Inc. Transaction History
Washington Trust Advisors, Inc.
- $1.06 Billion
- Q1 2024
A detailed history of Washington Trust Advisors, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 35 shares of MRNA stock, worth $4,141. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35
Previous 35
-0.0%
Holding current value
$4,141
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
1,038Shares Held
245MCall Options Held
12.1MPut Options Held
9.36M-
Baillie Gifford & CO44.7MShares$5.28 Billion3.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA39MShares$4.62 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY25.4MShares$3 Billion0.06% of portfolio
-
State Street Corp Boston, MA14.5MShares$1.71 Billion0.07% of portfolio
-
Flagship Pioneering Inc. Cambridge, MA9.67MShares$1.14 Billion67.87% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $46.3B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...